Antibiotics Market Size, Industry, Trend, Growth Analysis By 2028
2020 年抗生素市场价值为 441.1131 亿美元,预计 2028 年将达到 592.5324 亿美元;预计 2021-2028 年期间的复合年增长率为 4.0%。
抗生素是用于对抗细菌感染和疾病的强效药物。它们专门用于治疗由细菌引起的感染,例如葡萄球菌、链球菌或大肠杆菌。抗生素要么杀死细菌(杀菌剂),要么限制细菌繁殖和生长(抑菌剂)。市场上的抗生素对任何病毒感染都不起作用。用抗生素治疗的一些常见感染包括结膜炎、皮肤或软组织感染、上呼吸道感染、支气管炎、链球菌性咽炎(链球菌性咽喉炎)等。
市场洞察
仿制药发展日益活跃
仿制药是不再受专利保护的品牌药的复制品。仿制药被引入市场,旨在提供具有成本效益的药物,并扩大这些药物对不同经济阶层人群的覆盖范围。仿制药因其可用性和可负担性而受欢迎。例如,根据 2018 年 NCBI 上发表的一项研究,品牌药的平均处方价格几乎是仿制药平均价格的 4 倍。此外,这些公司还专注于开发仿制药,旨在以最低成本提供抗生素。例如,2018 年 6 月,鲁宾在美国市场推出了仿制妥布霉素吸入溶液。此外,政府部门的鼓励也预计将推动仿制药抗生素的生产,这最终将在预测期内推动抗生素市场的增长。例如,2019 年 2 月,美国食品药品监督管理局 (US FDA) 宣布批准印度制药公司在美国生产的仿制药商业化。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
抗生素市场:
复合年增长率(2020 - 2028 年)4.0%- 2020 年市场规模
441.1 亿美元 - 2028 年市场规模
592.5 亿美元
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- 辉瑞公司
- 强生服务公司(杨森制药),
- 雅培,
- 葛兰素史克公司,
- 赛诺菲,
- 诺华公司,
- 拜耳公司,
- 百时美施贵宝公司,
- 礼来公司,
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 磺胺类药物
- 氨基糖苷类
- 卡巴培南
- 大环内酯类
- 氟喹诺酮类
- 青霉素
- 头孢菌素
- 其他的
- 肌酸抑制剂
- RNA 合成抑制剂
- DNA 合成抑制剂
- 蛋白质合成抑制剂
- 细胞壁合成抑制剂
- 北美
- 欧洲
- 亚太地区
- 中东和非洲
- 南美洲和中美洲
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
测试类型洞察
根据药物类别,抗生素市场分为磺胺类、氨基糖苷类、卡巴培南类、大环内酯类、氟喹诺酮类、青霉素、头孢菌素等。头孢菌素类在 2020 年占据了最大的市场份额;而氟喹诺酮类预计在预测期内将实现最高的复合年增长率。
作用机制洞察
根据作用机制,抗生素市场细分为肌酸抑制剂、RNA 合成抑制剂、DNA 合成抑制剂、蛋白质合成抑制剂和细胞壁合成抑制剂。细胞壁合成抑制剂部分在 2020 年占据了最大的市场份额,而 DNA 合成抑制剂部分预计在预测期内在市场上的复合年增长率最高。
公司通常采用产品发布和批准策略来扩大其全球影响力和产品组合并满足日益增长的需求。
抗生素市场的市场参与者采用扩张战略来扩大全球客户群,这也使参与者能够在全球范围内维护其品牌名称。例如,2019 年 7 月,辉瑞等公司成立了一个国际研究联盟,与八家生物技术合作伙伴和欧洲学术机构合作,发现和开发新的结核病抗生素。
抗生素市场报告范围
报告属性 | 细节 |
---|---|
2020 年市场规模 | 441.1亿美元 |
2028 年市场规模 | 592.5亿美元 |
全球复合年增长率(2020 - 2028) | 4.0% |
历史数据 | 2018-2019 |
预测期 | 2021-2028 |
涵盖的领域 | 按药物类别
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
全球抗生素市场 – 按药物类别
- 头孢菌素
- 青霉素
- 氟喹诺酮类
- 大环内酯类
- 卡巴培南
- 氨基糖苷类
- 磺胺类药物
- 其他的
全球抗生素市场 – 按作用机制
- 细胞壁合成抑制剂
- 蛋白质合成抑制剂
- DNA 合成抑制剂
- RNA 合成抑制剂
- 肌酸抑制剂
- 其他的
全球抗生素 – 按地区划分
北美
- 我们
- 加拿大
- 墨西哥
欧洲
- 法国
- 德国
- 意大利
- 英国
- 西班牙
- 欧洲其他地区
亚太地区 (APAC)
- 中国
- 印度
- 韩国
- 日本
- 澳大利亚
- 亚太其他地区
中东和非洲 (MEA)
- 南非
- 沙特阿拉伯
- 阿联酋
- 中东和非洲其他地区
南美洲
- 巴西
- 阿根廷
- 南美洲其他地区
公司简介
- 辉瑞公司
- 强生服务公司(杨森制药),
- 雅培,
- 葛兰素史克公司,
- 赛诺菲,
- 诺华公司,
- 拜耳公司,
- 百时美施贵宝公司,
- 礼来公司,
- 安斯泰来制药
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Antibiotics are powerful medicines that are used to fight against bacterial infections. Antibiotics are also known as antibacterials which include a range of powerful drugs and are used to treat diseases caused by bacteria. These are specifically used to treat infections caused by bacteria such as, Staph., Strep., or E. coli. and either kill the bacteria (bactericidal) or keep it from reproducing and growing (bacteriostatic). The antibiotics do not work against any viral infection. Some common infections treated with antibiotics are, conjunctivitis, skin or soft tissue infection, upper respiratory tract infection, bronchitis, streptococcal pharyngitis (strep throat) and among others.
The North American region holds the largest market for the breast cancer screening. The United States held the largest market for antibiotics market and is expected to grow due to factors such as increasing number of rising in prevalence of breast cancer , growing developments for screening and imaging process by the companies and others.
The growth of the market is attributed to some key driving factors such as rising prevalence of bacterial infections, growing geriatric population and increasing development of generic drugs. However, tedious and expensive process of antibiotic development is expected to restraint the growth of the market during the forecast years.
The List of Companies - Antibiotics Market
- Pfizer, Inc
- Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals),
- Abbott,
- GlaxoSmithKline Plc,
- Sanofi,
- Novartis AG,
- Bayer AG,
- Bristol Myers Squibb Company,
- Eli Lilly and Company,
- Astellas Pharma
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.